Scientist/Senior Scientist, Discovery Biology and Proteomics
Watertown, Massachusetts, United States · On-site
Senior$295M raised
What’s the opportunity? LifeMine Therapeutics is seeking a highly motivated Scientist to join our Discovery Biology team located in Watertown, MA. We are seeking an experienced and self-directed Senior Scientist to build…
Skills: Mass Spectrometry, Proteomics, LC-MS/MS, Chemical Biology, Sample Preparation
What’s the opportunity? LifeMine Therapeutics is seeking an experienced and results-driven Manager/Sr Manager, Clinical Operations to join our growing Clinical Development team. Reporting to the Director of Clinical Oper…
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Full-time
postgraduate degree
Posted 26d ago
~40 hrs/week
Responsibilities
The role involves building proteomics capabilities to evaluate immunomodulatory response mechanisms and drug-target interactions. Responsibilities include designing bottom-up proteomics workflows and applying chemical biology tools to support mechanism-of-action studies.
Requirements
Requires a Ph.D. in Biochemistry, Chemical Biology, or a related field with over 4 years of postdoctoral or industry experience in mass spectrometry-based proteomics. Candidates must have proven hands-on experience with LC-MS/MS instrument operation and interactome profiling.
Full job description
What’s the opportunity?
LifeMine Therapeutics is seeking a highly motivated Scientist to join our Discovery Biology team located in Watertown, MA. We are seeking an experienced and self-directed Senior Scientist to build proteomics capabilities within our research organization. This is a hands-on, lab-based role for a scientist who thrives at the intersection of chemical biology, mass spectrometry, and mechanistic biology. The ideal candidate brings deep technical expertise in proteomics paired with strong biological intuition. You are comfortable working independently from end-to-end pre-clinical drug discovery to presenting mechanistic data to leadership. You take ownership of your platform and your science, and you are energized by the challenge of building something new and making it work in service of meaningful drug discovery.
Key Responsibilities:
Propose study designs and conduct experiments to evaluate immunomodulatory response mechanisms in vitro and in vivo. Interpret data in the context of disease biology, signaling pathways, and therapeutic hypotheses; translate findings into actionable insights for cross-functional teams.
Design and execute bottom-up proteomics workflows including sample preparation (protein digestion, fractionation, enrichment), LC-MS/MS acquisition, and data analysis using tools such as MaxQuant, DIA-NN, Spectronaut, and Skyline
Perform affinity-based pulldown and co-immunoprecipitation experiments coupled with MS to identify protein-protein interactors and characterize target interactomes.
Execute CETSA (Cellular Thermal Shift Assay) and related target engagement assays to assess drug-target interaction in cellular contexts
Apply chemical biology tools including activity-based probes, photoaffinity labeling, and chemically modified ligands to support mechanism-of-action studies.
Partner closely with biology and translational teams to design experiments that address key program questions and efficiently contribute to clinical studies.
Communicate results clearly through presentations, reports, and scientific discussions with internal and external stakeholders.
Stay current with advances in proteomics technology, chemical biology, and relevant disease biology; bring new methodologies into the group proactively.
What you will need to be successful:
Ph.D. in Biochemistry, Chemical Biology, Proteomics, Analytical Chemistry, or a related field
4+ years of postdoctoral or industry experience with a strong focus on mass spectrometry-based proteomics
Proven hands-on experience with LC-MS/MS instrument operation (orbitrap, tribrid and timsTOF), method development, and troubleshooting
Demonstrated experience in bottom-up proteomics workflows (global, PTM enrichment) from sample preparation through data analysis
Experience with affinity pulldown/AP-MS or interactome profiling experiments is a must
Familiarity with CETSA or other thermal proteome profiling (TPP) approaches
Proficient using chemical biology tools for target identification and MoA studies
Strong biological understanding with the ability to contextualize proteomic findings within cellular and disease biology
Track record of independent experimental design, execution, and troubleshooting
Excellent communication skills; ability to present complex data to diverse audiences
LifeMine is a biopharmaceutical company pioneering Top-Down Drug Discovery™, a new approach that leverages evolution.
Industry
Biotechnology
Company size
51-200 employees
Founded
2017
Headquarters
Cambridge, MA
LinkedIn followers
12,916
Total funding
$295M
LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines. LifeMine’s data-immersive platform integrates the latest advancements in human genetics and genomics, bioinformatics, machine learning and synthetic biology. LifeMine’s lead program, LIFE-001, is a novel, precision-engineered, long-acting calcineurin inhibitor being developed for multiple immunologic disorders and organ transplantation.
Offices: Cambridge Discovery Park, 30 Acorn Park Drive, 6th Floor, Cambridge, MA 02140, US · Basel, CH
LifeMine is a biopharmaceutical company pioneering Top-Down Drug Discovery™, a new approach that leverages evolution.
Industry
Biotechnology
Company size
51-200 employees
Founded
2017
Headquarters
Cambridge, MA
LinkedIn followers
12,916
Total funding
$295M
LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines. LifeMine’s data-immersive platform integrates the latest advancements in human genetics and genomics, bioinformatics, machine learning and synthetic biology. LifeMine’s lead program, LIFE-001, is a novel, precision-engineered, long-acting calcineurin inhibitor being developed for multiple immunologic disorders and organ transplantation.
Offices: Cambridge Discovery Park, 30 Acorn Park Drive, 6th Floor, Cambridge, MA 02140, US · Basel, CH